- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04048044
EFFECTS OF RejuvaMatrix ™ ON TELOMERES
THE EFFECTS OF THE RejuvaMatrix ™ ON TELOMERES
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Individuals who are post menopausal and who do not have an implanted electronic device, such as a pacemaker will have base line white blood cell telomeeres measured at Repeat Diagnostics in Vancouver. They will be supplied with a two inch foam mat in the center of which is copper screen with one pound of crushed sapphire. The mat looks like a mattreess and is placed on top of the regular mattress. Participants are provided with a Tesla coil to be attached to a copper wire coming from the copper screen. They will also be provided with a timer so that they can set the Tesla coil to be activated for a maximum of 60 minutes while they sleep.
Telomeres will be measured at the end of each year for 5 years.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
Exclusion Criteria:
- Implanted electronic device
- Major, debilitating disease
- Person living with an individual who has an implanted device
- Person who is or could become pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Telomere length, GigaHz exposure
Measurement of white blood cell telomeres before and yearly for 5 years
|
75 decibels of 54 to 78 GHz daily for 60 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Length of telomeres after 5 years compared with baseline
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total Symptom Index
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HIH RM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Telomeres
-
IVI MadridRecruitingSperm | Sperm DNA Fragmentation | Male Fertility | TelomeresSpain
Clinical Trials on Exposure to GHz electromagnetic energy (RejuvaMatrix)
-
Plasma Surgical IncCompletedSkin AgingUnited States
-
The Federal Office for Radiation Protection, GermanySeibersdorf Labor GmbHCompleted